Taurine is a conditionally essential micronutrient and one of the most abundant amino acids in humans1–3. In endogenous taurine metabolism, dedicated enzymes are involved in the biosynthesis of taurine from cysteine and in the downstream metabolism of secondary taurine metabolites4,5. One taurine metabolite is N-acetyltaurine6. Levels of N-acetyltaurine are dynamically regulated by stimuli that alter taurine or acetate flux, including endurance exercise7, dietary taurine supplementation8 and alcohol consumption6,9. So far, the identities of the enzymes involved in N-acetyltaurine metabolism, and the potential functions of N-acetyltaurine itself, have remained unknown. Here we show that the body mass index associated orphan enzyme phosphotriesterase-related (PTER)10 is a physiological N-acetyltaurine hydrolase. In vitro, PTER catalyses the hydrolysis of N-acetyltaurine to taurine and acetate. In mice, PTER is expressed in the kidney, liver and brainstem. Genetic ablation of Pter in mice results in complete loss of tissue N-acetyltaurine hydrolysis activity and a systemic increase in N-acetyltaurine levels. After stimuli that increase taurine levels, Pter knockout mice exhibit reduced food intake, resistance to diet-induced obesity and improved glucose homeostasis. Administration of N-acetyltaurine to obese wild-type mice also reduces food intake and body weight in a GFRAL-dependent manner. These data place PTER into a central enzymatic node of secondary taurine metabolism and uncover a role for PTER and N-acetyltaurine in body weight control and energy balance.
Conformational biasing (CB) is a rapid and streamlined computational method that uses contrastive scoring by inverse folding models to predict protein variants biased toward desired conformational states. We successfully validated CB across seven diverse datasets, identifying variants of K-Ras, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein, the β2 adrenergic receptor, and Src kinase with improved conformation-specific functions such as enhanced binding or enzymatic activity. Applying CB to the enzyme lipoic acid ligase (LplA), we uncovered a previously unknown mechanism controlling its promiscuous activity. Variants biased toward an “open” conformation state became more promiscuous, whereas “closed”-biased variants were more selective, enhancing LplA’s utility for site-specific protein labeling with fluorophores in living cells. The speed and simplicity of CB make it a versatile tool for engineering protein dynamics with broad applications in basic research, biotechnology, and medicine.
Most natural proteins alternate between distinct conformational states, each associated with specific functions. Intentional manipulation of conformational equilibria could lead to improved or altered protein properties. Here we develop Conformational Biasing (CB), a rapid and streamlined computational method that utilizes contrastive scoring by inverse folding models to predict variants biased towards desired conformational states. We validated CB across seven diverse deep mutational scanning datasets, successfully predicting variants of K-Ras, SARS-CoV-2 spike, β2 adrenergic receptor, and Src kinase with improved conformation-specific functions including enhanced effector binding or enzymatic activity. Furthermore, applying CB to lipoic acid ligase, a conformation-switching bacterial enzyme that has been used for the development of protein labeling technologies, revealed a previously unknown mechanism for conformational gating of sequence-specificity. Variants biased toward the “open” conformation were highly promiscuous, while “closed” conformation-biased variants were even more specific than wild-type, enhancing the utility of LplA for site-specific protein labeling with fluorophores in living cells. The speed, simplicity, and versatility of CB (available at: https://github.com/alicetinglab/ConformationalBiasing/ ) suggest that it may be broadly applicable for understanding and engineering protein conformational dynamics, with implications for basic research, biotechnology, and medicine.